Oppenheimer Reiterates Outperform on Compass Pathways, Maintains $20 Price Target
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsReiterationPrice Target
Oppenheimer analyst Francois Brisebois reiterates Compass Pathways (NASDAQ:CMPS) with a Outperform and maintains $20 price target.
Oppenheimer analyst Francois Brisebois reiterates Compass Pathways (NASDAQ:CMPS) with a Outperform and maintains $20 price target.